Bain Capital Public Equity Management II, LLC - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.

Quarter-by-quarter ownership
Bain Capital Public Equity Management II, LLC ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q2 2022$9,302,000
-2.1%
249,318
-21.5%
0.46%
+50.7%
Q1 2022$9,499,000
-61.0%
317,676
-55.4%
0.30%
-62.6%
Q4 2021$24,377,000
+3.0%
711,951
+11.6%
0.81%
-1.7%
Q3 2021$23,658,000
+27.7%
638,205
+34.5%
0.83%
+4.3%
Q2 2021$18,531,000
+44.7%
474,554
+57.7%
0.79%
+48.5%
Q1 2021$12,808,000300,8710.53%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q2 2022
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders